Biodesix, Inc.
Biodesix, Inc., a leading player in the precision medicine industry, is headquartered in the United States. Founded in 2010, the company has made significant strides in the development of innovative diagnostic solutions, particularly in the field of lung cancer. Biodesix focuses on utilising advanced genomic and proteomic technologies to provide actionable insights for oncologists, enhancing patient care through personalised treatment options. The company’s core offerings include its proprietary blood-based tests, which are designed to identify specific biomarkers associated with lung cancer. This unique approach not only aids in early detection but also helps in tailoring therapies to individual patient profiles. Biodesix has established a strong market position, recognised for its commitment to improving patient outcomes and advancing the field of oncology diagnostics.
DitchCarbon Score
How does Biodesix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biodesix, Inc.'s score of 32 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biodesix, Inc.'s reported carbon emissions
Biodesix, Inc., headquartered in the United States, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. However, the company has made significant climate commitments. Biodesix is committed to near-term climate targets, as evidenced by their participation in the Science Based Targets initiative (SBTi), where they have been classified as "Committed." Additionally, Biodesix has signed the Climate Pledge, affirming their dedication to sustainability and climate action since March 21, 2022. This pledge aligns with their operational focus within the healthcare sector, which includes healthcare providers and services, as well as healthcare technology. While specific reduction targets or achievements have not been disclosed, Biodesix's commitment to climate initiatives reflects a proactive approach to addressing environmental impacts within their industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biodesix, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
